Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05617157 · ClinicalTrials.gov registry record · NA
Effects of Stair Stepping on Late Day Postprandial Glycemia
A NA study of Glycemic Control, sponsored by San Diego State University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05617157: Completed NA study of Glycemic Control, sponsored by San Diego State University.
NCT05617157 is a NA study of Glycemic Control that has completed, run by San Diego State University. The registered enrollment target is 30 participants, below the 305-participant average among 3 other Glycemic Control trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05617157, a NA study of Glycemic Control, has completed, sponsored by San Diego State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
1. Purpose/objective: The purpose of the current study is to investigate whether the benefits of stair stepping established for early day food consumption extend to late day food consumption. 2. Methods: Participants will perform two standard oral glucose tolerance test (OGTT), consuming 75g of glucose dissolved in 350mL of water followed by assessment of glycemic markers for 2 hours. Participants will perform the OGTTs in the evening of two separate days. One day will be the control condition, where participants will remain seated throughout the entire duration of the OGTT. The other day (in randomized order) participants will perform 1 min of stair stepping at a self-selected, comfortable pace 28min after the consumption of the glucose solution. Blood glucose measurement via standard, over the counter finger sticks will be performed every 10 min for the first hour, and again at 90 and 120min of the OGTT. In addition, standard venipuncture blood draws (5mL) will be drawn at baseline ad at peak (30min) glucose excursion for the assessment of insulin. Participants will be instructed to not vary their diet or exercise during the two testing days. Diet and activity logs will be collected and analyzed to verify compliance. 3. Subjects Adults 18 or over will be recruited for this project. Prior to enrolling in the study, each potential participant will complete the Physical Activity Recall Questionnaire (PAR-Q+) to screen for cardiovascular risks. Any positive responses to questions from the PAR-Q+ will eliminate the individual from selection. Participants who self report any condition that will prevent them form safely and/or comfortably climbing stairs will also be excluded form participation. 4. Planned analyses: Results will be analyzed via a 2-factor repeated measure analysis of variance for time and condition. Statistical significance will be set at an alpha level of 0.05. 5. Potential benefits: This study will help to identify the shortest possible bou
Primary Outcome
Plasma Glucose
Conditions Studied
Interventions
- OTHER Stair stepping
Study Locations (1)
California
- San Diego State University - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2024-05-07 |
| Phase | NA |
What the finished NCT05617157 record still lists
NCT05617157 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 305-participant average among 3 other Glycemic Control trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Glycemic Control appearing as the primary indexed condition, and to 1 intervention - of which Stair stepping is the first listed.
NCT05617157 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05617157 about?
NCT05617157 is a clinical study titled "Effects of Stair Stepping on Late Day Postprandial Glycemia". 1. Purpose/objective: The purpose of the current study is to investigate whether the benefits of stair stepping established for early day food consumption extend to late day food consumption. 2. Methods: Participants will perform two standard oral glucose tolerance test (OGTT), consuming 75g...
What is the current status of trial NCT05617157?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2022-12-01. Estimated completion is 2024-05-07.
What conditions does trial NCT05617157 study?
This clinical trial studies the following conditions: Glycemic Control.
What interventions are being tested in trial NCT05617157?
The interventions under investigation include: Stair stepping (OTHER).
Who is sponsoring clinical trial NCT05617157?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05617157 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glycemic Control
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI